About Rapid Micro Biosystems Inc
Ticker
info
RPID
Trading on
info
NASDAQ
ISIN
info
US75340L1044
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Robert G. Spignesi Jr.
Headquarters
info
25 Hartwell Avenue, Lexington, MA, United States, 02421
Employees
info
163
Website
info
rapidmicrobio.com
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$156M
P/E ratio
info
-
EPS
info
-$1.03
Dividend Yield
info
0.00%
Beta
info
1.34
Forward P/E ratio
info
0
EBIDTA
info
$-44.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$156M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
5.25
Price to book
info
2.38
Earnings
EPS
info
-$1.03
EPS estimate (current quarter)
info
-$0.27
EPS estimate (next quarter)
info
-$0.27
EBITDA
info
$-44.3M
Revenues (TTM)
info
$29.6M
Revenues per share (TTM)
info
$0.68
Technicals
Beta
info
1.34
52-week High
info
$4.04
52-week Low
info
$0.58
50-day moving average
info
$2.81
200-day moving average
info
$1.84
Short ratio
info
4.78
Short %
info
5.93%
Management effectiveness
ROE (TTM)
info
-52.30%
ROA (TTM)
info
-27.74%
Profit margin
info
-151.22%
Gross profit margin
info
$1.8M
Operating margin
info
-161.85%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
28.40%
Share stats
Outstanding Shares
info
39.3M
Float
info
19.1M
Insiders %
info
10.66%
Institutions %
info
60.54%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 3 analysts.

Average price target

info
$8.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.29
-$0.28
-3.57%
Q2 • 24Missed
-$0.26
-$0.26
-1.96%
Q3 • 24Missed
-$0.22
-$0.23
2.22%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$8.2M
$-9.7M
-117.62%
Q4 • 24
$7.2M
$-11.3M
-156.32%
Q1 • 25
-12.33%
16.52%
32.90%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$98.2M
$22.8M
23.24%
Q4 • 24
$85.4M
$19.9M
23.34%
Q1 • 25
-12.97%
-12.60%
0.43%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-9.9M
$4.9M
$-0M
$-10M
Q4 • 24
$-9.1M
$10.7M
$0.4M
$-9.4M
Q1 • 25
-8.52%
119.64%
-6,416.67%
-6.23%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Rapid Micro Biosystems Inc share?
Collapse

Rapid Micro Biosystems Inc shares are currently traded for undefined per share.

How many shares does Rapid Micro Biosystems Inc have?
Collapse

Rapid Micro Biosystems Inc currently has 39.3M shares.

Does Rapid Micro Biosystems Inc pay dividends?
Collapse

No, Rapid Micro Biosystems Inc doesn't pay dividends.

What is Rapid Micro Biosystems Inc 52 week high?
Collapse

Rapid Micro Biosystems Inc 52 week high is $4.04.

What is Rapid Micro Biosystems Inc 52 week low?
Collapse

Rapid Micro Biosystems Inc 52 week low is $0.58.

What is the 200-day moving average of Rapid Micro Biosystems Inc?
Collapse

Rapid Micro Biosystems Inc 200-day moving average is $1.84.

Who is Rapid Micro Biosystems Inc CEO?
Collapse

The CEO of Rapid Micro Biosystems Inc is Robert G. Spignesi Jr..

How many employees Rapid Micro Biosystems Inc has?
Collapse

Rapid Micro Biosystems Inc has 163 employees.

What is the market cap of Rapid Micro Biosystems Inc?
Collapse

The market cap of Rapid Micro Biosystems Inc is $156M.

What is the P/E of Rapid Micro Biosystems Inc?
Collapse

The current P/E of Rapid Micro Biosystems Inc is null.

What is the EPS of Rapid Micro Biosystems Inc?
Collapse

The EPS of Rapid Micro Biosystems Inc is -$1.03.

What is the PEG Ratio of Rapid Micro Biosystems Inc?
Collapse

The PEG Ratio of Rapid Micro Biosystems Inc is 0.

What do analysts say about Rapid Micro Biosystems Inc?
Collapse

According to the analysts Rapid Micro Biosystems Inc is considered a buy.